AI assistant
Sending…
IMMUCELL CORP /DE/ — Director's Dealing 2011
Jun 23, 2011
34519_dirs_2011-06-23_766b0f5f-60de-4a13-b802-1eafa0d66b95.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: IMMUCELL CORP /DE/ (ICCC)
CIK: 0000811641
Period of Report: 2011-06-21
Reporting Person: Tomsche David Scott (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2011-06-21 | Common Stock ($0.10) | P | 785 | $6.24 | Acquired | 34258 | Indirect |
| 2011-06-21 | Common Stock ($0.10) | P | 775 | $6.25 | Acquired | 35033 | Indirect |
| 2011-06-21 | Common Stock ($0.10) | P | 762 | $6.24 | Acquired | 35795 | Indirect |
Footnotes
F1: Purchased for the Roth account of Carson Tomsche, Dr. Tomsche's son.
F2: Purchase for the Roth account of Morgan Tomsche, Dr. Tomsche's daughter.
F3: Purchased for the IRA account of Mollly Tomsche, Dr. Tomsche's spouse.
More from IMMUCELL CORP /DE/
Regulatory Filings
2026
May 14
Annual Report
2026
May 13
Regulatory Filings
2026
May 8
Proxy Solicitation & Information Statement
2026
Apr 24
Regulatory Filings
2026
Apr 14
Regulatory Filings
2026
Apr 14
Regulatory Filings
2026
Apr 8
Annual Report
2026
Mar 30
Director's Dealing
2026
Mar 25
Director's Dealing
2026
Mar 23